Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

Two researchers independently screened, extracted data, and assessed quality using the Newcastle-Ottawa Scale (NOS) and Revman5.3. Meta-analysis with Stata 16.0 calculated the combined Odd ratio (OR) for WHR and MI risk.

Myocardial Infarction 52

Myocardial Infarction Research 52

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

ST-elevation myocardial infarction (STEMI) is a critical cardiovascular emergency characterized by acute coronary artery occlusion and subsequent myocardial injury. Finally, the clinical evidence is critically assessed, existing controversies are analyzed, and directions for future research are proposed.

Thrombolysis 52

Thrombolysis STEMI Myocardial Infarction Article 52

Science Daily - Heart Disease

JUNE 10, 2024

New research discovers a potential path to prevent permanent scarring and heart failure following a myocardial infarction.

Heart Attack 115

Heart Attack Heart attacks Myocardial Infarction Heart Failure 115

Cardiovascular Diabetology

MAY 26, 2024

Stress hyperglycemia, which is associated with poor prognosis in patients with acute myocardial infarction (AMI), can be determined using the stress hyperglycemia ratio (SHR). Impaired left ventricular functio.

Myocardial Infarction 78

Myocardial Infarction Research 78

Cardiovascular Diabetology

JANUARY 17, 2025

The aim of this study was to investigate the difference between perceived and calculated diabetes risks among post-myocardial infarction (AMI) patients using the Finnish Diabetes Risk Score (FINDRISC).

Myocardial Infarction 64

Myocardial Infarction Diabetes Research 64

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

Cardio-cerebral infarction (CCI) is a rare clinical syndrome characterized by the simultaneous or sequential occurrence of acute myocardial infarction (AMI) and acute ischemic stroke (AIS).

Myocardial Infarction 52

Myocardial Infarction Article Research Patient Care 52

Cardiovascular Diabetology

JANUARY 21, 2024

It is well-known that systemic inflammation plays a crucial role in the pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune-inflammation index (SII, platelet × neutrophil/lymph.

Myocardial Infarction 72

Myocardial Infarction Diabetes Research 72

Cardiovascular Diabetology

JANUARY 21, 2025

The impact of sodiumglucose cotransporter-2 (SGLT2) inhibitors on mortality following myocardial infarction (MI) remains uncertain. Additionally, the role of type 2 diabetes mellitus (T2DM) and heart failure.

Myocardial Infarction 64

Myocardial Infarction Heart Failure Diabetes Research 64

Med Page Today

FEBRUARY 21, 2024

(MedPage Today) -- For the first time, intravascular imaging-guided coronary stenting was associated with better survival and reduced myocardial infarction (MI) in a meta-analysis powered to detect these benefits against angiography, researchers.

Myocardial Infarction 110

Myocardial Infarction Stent Stents Research 110

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

Chronic obstructive pulmonary disease (COPD), particularly following acute exacerbations (AE-COPD), significantly heightens the risks and mortality associated with acute myocardial infarction (AMI).

Myocardial Infarction 64

Myocardial Infarction Pulmonary Research 64

Journal of Cardiothoracic Surgery

MARCH 24, 2025

The objective was to assess the clinical efficacy of long non-coding RNA (lncRNA) alpha-2-macroglobulin-antisense 1 (A2M-AS1) in acute myocardial infarction (AMI).

Myocardial Infarction 52

Myocardial Infarction Research 52

Frontiers in Cardiovascular Medicine

APRIL 1, 2025

The paucity of data necessitates further research to elucidate the pathophysiological connection between depression and cardiac diseases in the presence of N-terminal pro-brain natriuretic peptide (NT-proBNP). IntroductionDepression is a significant comorbidity linked to poor subjective and objective health outcomes in cardiac patients.

Biomarkers 52

Biomarkers Coronary Artery Disease Article Myocardial Infarction 52

Cardiovascular Diabetology

AUGUST 15, 2024

Diabetes mellitus (DM) and coronary microvascular dysfunction (CMD) increase the risk of adverse cardiac events in patients with non-ST-segment elevation myocardial infarction (NSTEMI). This study aimed to eva.

Myocardial Infarction 59

Myocardial Infarction Diabetes Research 59

Medical Xpress - Cardiology

MAY 16, 2024

When the heart is injured, as in a myocardial infarction, the damaged heart muscle cannot regenerate—instead, scar tissue forms. Cardiomyocytes, the heart muscle cells that generate contractile force, are lost for good. Yet, in mouse models, the hearts of newborns regenerate readily after injury.

Myocardial Infarction 73

Myocardial Infarction Research 73

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Therefore, this paper proposes a novel cost-sensitive deep neural network (CSDNN)-based mortality prediction model for out-of-hospital acute myocardial infarction (AMI) patients with hypertension on imbalanced data. Methods The synopsis of our research is as follows.

Myocardial Infarction 64

Myocardial Infarction Hypertension Risk Factors Cardiovascular Disease 64

Cardiovascular Diabetology

SEPTEMBER 2, 2024

Despite the detrimental impact of abnormal glucose metabolism on cardiovascular prognosis after myocardial infarction (MI), diabetes is both underdiagnosed and undertreated. We investigated associations betwee.

Myocardial Infarction 59

Myocardial Infarction Diabetes Cardiac Rehabilitation Research 59

Frontiers in Cardiovascular Medicine

APRIL 3, 2025

Despite this, the patient went on to develop chest pain, which was accompanied by electrocardiographic signs of acute extensive anterior wall myocardial infarction and elevated troponin I levels.

COVID-19 52

COVID-19 Chest Pain Myocardial Infarction Laboratory 52

Journal of the American Heart Association

APRIL 3, 2025

BackgroundMyocardial fibrosis is a pathological hallmark of heart failure post infarction, emphasizing the need for innovative treatment strategies. Journal of the American Heart Association, Ahead of Print. Mesenchymal stem cellderived EVs, loaded with PAP, were encapsulated in the SA hydrogel (EVsPAP@SA).

Myocardial Infarction 45

Myocardial Infarction Innovation Heart Failure Research 45

Cardiovascular Diabetology

JANUARY 5, 2025

Inflammatory diseases impair the reparative properties of endothelial progenitor cells (EPC); however, the involvement of diabetes in EPC dysfunction associated with myocardial infarction (MI) remains unknown.

Myocardial Infarction 52

Myocardial Infarction Diabetes Research 52

Journal of Cardiothoracic Surgery

SEPTEMBER 5, 2024

The purpose of this study was to investigate the diagnostic value of circ_0013958 in acute myocardial infarction (AMI) patients and its influence on the prognosis of AMI patients.

Myocardial Infarction 52

Myocardial Infarction Research 52

Cardiovascular Diabetology

APRIL 26, 2024

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been suggested to exert cardioprotective effects in patients with heart failure, possibly by improving the metabolism of ketone bodies in the myocardium.

Myocardial Infarction 105

Myocardial Infarction Heart Failure Research 105

Cardiovascular Diabetology

DECEMBER 11, 2023

Previous observational studies have documented an inverse association of birthweight with myocardial infarction (MI) but a positive association with atrial fibrillation (AF). However, the causality of these as.

Myocardial Infarction 59

Myocardial Infarction Atrial Fibrillation Document Research 59

Journal of Cardiothoracic Surgery

FEBRUARY 7, 2025

High levels of MG53 may attenuate the damage from myocardial infarction (MI). Furthermore, N6-methyl-adenosine (m6A) methylation is a mode of RNA modification that influences mRNA functions. Whether m6A modifi.

Myocardial Infarction 52

Myocardial Infarction Research 52

Cardiovascular Diabetology

OCTOBER 29, 2024

Type 2 diabetes has traditionally been a risk factor for worse prognosis after myocardial infarction (MI), but major advances have been made in its treatment, and the use of secondary preventive measures has i.

Myocardial Infarction 52

Myocardial Infarction Diabetes Risk Factors Research 52

Journal of Cardiothoracic Surgery

FEBRUARY 19, 2025

Patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) face high mortality rates. Extracorporeal Membrane Oxygenation (ECMO) therapy offers critical support in these cases, yet i.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Risk Factors Research 52

Cardiovascular Diabetology

JUNE 19, 2024

Stress hyperglycemia occurs frequently in patients following acute myocardial infarction (AMI) and may aggravate myocardial stiffness, but relevant evidence is still lacking. Accordingly, this study aimed to e.

Myocardial Infarction 52

Myocardial Infarction Research 52

Cardiovascular Diabetology

AUGUST 6, 2024

Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Results Among all patients (n = 38,671), 31% had stable CAD, and 69% suffered an acute myocardial infarction.

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

Open Heart

MARCH 4, 2022

Objective To collate existing qualitative research examining patients’ medication-taking experiences in secondary prevention of acute myocardial infarction (AMI) and produce new knowledge, a systematic review and meta-synthesis of patient qualitative studies was conducted.

Myocardial Infarction 52

Myocardial Infarction Research 52

Heart BMJ

JULY 10, 2024

Background Despite restoration of epicardial blood flow in acute ST-elevation myocardial infarction (STEMI), inadequate microcirculatory perfusion is common and portends a poor prognosis. Further research is needed to optimise the selection of thrombolytic agents and treatment protocols.

Myocardial Infarction 52

Myocardial Infarction Thrombolysis STEMI Outcomes 52

Frontiers in Cardiovascular Medicine

MARCH 27, 2025

The clinical outcomes assessed included all-cause mortality, cardiac-specific mortality, myocardial infarction (MI), repeat revascularization, stroke, sternal wound complications, and major bleeding. We conducted a comprehensive search across multiple databases for RCTs that directly compared MAG and SAG.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Myocardial Infarction Stroke Strokes 52

Medical Xpress - Cardiology

SEPTEMBER 3, 2024

The benefits of complete revascularization over culprit-only coronary artery revascularization were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Myocardial Infarction 40

Myocardial Infarction STEMI Research 40

Medical Xpress - Cardiology

JANUARY 28, 2025

A new study by researchers at Karolinska Institutet and Sdersjukhuset shows that advanced ultrasound imaging analyses cannot identify patients who would benefit from beta-blocker treatment after a myocardial infarction.

Myocardial Infarction 40

Myocardial Infarction Ultrasound Research 40

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Individual outcomes, including all-cause mortality, myocardial infarction, and revascularization, also showed no significant differences between the two groups. After PS matching, the POCE incidence remained similar between the two groups (3.7% vs. 3.4%, HR 1.01, 95% CI 0.76–1.35, 1.35, p = 0.931).

Myocardial Infarction 45

Myocardial Infarction Kidney Disease Outcomes Research 45

Journal of Cardiothoracic Surgery

FEBRUARY 12, 2025

Percutaneous coronary intervention (PCI) can effectively restore myocardial perfusion in patients with ST-segment elevation myocardial infarction (STEMI). Nevertheless, STEMI patients may still experience a n.

Myocardial Infarction 52

Myocardial Infarction STEMI Research 52

Journal of Cardiothoracic Surgery

SEPTEMBER 22, 2024

The purpose of this study was to explore the expression of miR-665 in acute myocardial infarction (AMI) and evaluate its significance in the diagnosis and prognosis of AMI.

Myocardial Infarction 52

Myocardial Infarction Stenosis Research 52

Cardiovascular Diabetology

FEBRUARY 17, 2025

We aimed to develop and validate prediction models for stroke and myocardial infarction (MI) in pati. Digitalization and big health system data open new avenues for targeted prevention and treatment strategies.

Myocardial Infarction 52

Myocardial Infarction Stroke Strokes Diabetes 52

Cardiovascular Diabetology

JANUARY 5, 2024

Few studies explored the effect of the combination of glucose sodium-cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on the incidence of cardiovascular events in pa.

Myocardial Infarction 106

Myocardial Infarction Diabetes Research 106